S. Kitabatake

发表

Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C.

H. Toyoda, Y. Murakami, M. Tanikawa, 2013, Cytokine.

Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Relationship between Lens culinaris agglutinin‐reactive α‐fetoprotein and pathologic features of hepatocellular carcinoma

T. Kuzuya, H. Toyoda, M. Isogai, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic response

H. Toyoda, S. Yasuda, M. Tanikawa, 2020, GastroHep.

Post‐treatment levels of α‐fetoprotein predict long‐term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C

H. Toyoda, J. Tanaka, M. Tanikawa, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Viral eradication reduces all‐cause mortality, including non–liver‐related disease, in patients with progressive hepatitis C virus‐related fibrosis

H. Toyoda, J. Tanaka, M. Tanikawa, 2017, Journal of gastroenterology and hepatology.

Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Journal of Gastroenterology.

HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.

H. Toyoda, J. Tanaka, M. Tanikawa, 2016, Journal of hepatology.

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

Takanori Ito, H. Toyoda, M. Tanikawa, 2015, Journal of gastroenterology and hepatology.

Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000

T. Kuzuya, T. Honda, H. Toyoda, 2004, Cancer.

Impact of the branched‐chain amino acid to tyrosine ratio and branched‐chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis

H. Toyoda, M. Tanikawa, T. Kumada, 2015, Journal of gastroenterology and hepatology.

Confocal endomicroscopy for the diagnosis of gastric cancer in vivo

Y. Hirooka, O. Maeda, R. Miyahara, 2006, Endoscopy.

Utility of the FIB‐4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels

H. Toyoda, M. Tanikawa, T. Kumada, 2015, Journal of viral hepatitis.

Oral supplementation with branched‐chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C‐related cirrhosis: A propensity score analysis

Kenta Yamamoto, Takanori Ito, H. Toyoda, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

Takanori Ito, H. Toyoda, M. Tanikawa, 2015, Journal of gastroenterology and hepatology.